Multiple Sclerosis Journal - October 2017 - 1472

Multiple Sclerosis Journal 23(11)
summation images in MNI space. The CIC
Neuroanatomical Atlas was non-linearly deformed
into the individual's space, via mapping of
T1-weighted MR imaging data, to obtain a personalised anatomical parcellation of regions of interest,
which were used to generate time-activity curves for
the caudate and voxel-wise for the whole brain. The
whole spectroscopy voxel mask and the WML,
NAWM and grey matter masks within the spectroscopy voxel were rigid registered to the MNI space.
The Logan graphical reference method20 using a reference tissue time-activity curve as the input function
and model fitting performed with linear regression
was used to estimate the distribution volume ratio
(DVR) at the voxel level to produce parametric DVR
maps, relative to the caudate nucleus volume of distribution (VT). All masks were applied to the PET parametric DVR image to obtain the DVR for the
respective regions of interest.
We chose to use a normalised quantitation to allow
studies to be conducted without an arterial line. [11C]
PBR28 VT has a high test-retest variability of approximately 20%, the major contribution to which appears
to come in the blood to tissue transfer modelling.21
Alternatively, reference-based methods show less
test-retest variability (5% or less).21 While TSPO is
expressed throughout the brain, lower levels of specific binding within a proposed pseudo-reference
region do not affect the reliability of the parameter
estimates, although this may lead to underestimation
of relative binding differences between regions of
interest.22 We used the caudate nucleus as a pseudoreference region as relatively lower levels of microglial activity and TSPO expression is found in the
caudate and normalised standardised uptake ratios are
low in caudate compared to other brain regions.12,23
Statistical analyses
Statistical analyses were performed using SPSS software (IBM, SPSS v22). The Shapiro-Wilk test (with
p-value <0.05 considered significant) and Q-Q plots
for normality found that the following variables did not
pass the tests for normality: EDSS (p = 0.008), MSFC
(p = 2 × 10−4), [11C]PBR28 DVR in NAWM (p = 0.04)
and in WML (p = 0.03) of the spectroscopy voxel.
The non-parametric Spearman's correlation coefficient therefore was used for correlational analyses,
unless otherwise stated. Descriptive statistics were
reported as median and range, unless otherwise
stated. A p-value of less than 0.05 was considered
significant for all statistical tests. A multivariate
1472

Table 1. Summary of the clinical disability characteristics,
grey matter volume and positron-emission tomography
(PET) [11C]PBR28 distribution volume ratio for all
multiple sclerosis patients.

EDSS
Disease duration (years)
MSFC (z-score)
25FTW (seconds)
9HPT (seconds)
Whole brain grey matter
volume (cm3)
DVR spectroscopy voxel
Whole voxel
White matter lesions
NAWM
Grey matter

Median

Range

5.0
13
−0.09
7.4
23.3
791

1.0-7.0
1-28
−5.99 to 0.69
3.3-138.4
17.7-75.2
545-946

1.26
0.97
1.10
1.44

0.99-1.79
0.61-1.74
0.79-1.72
1.12-1.87

EDSS: Expanded Disability Status Scale; MSFC: Multiple
Sclerosis Functional Composite; 25FTW: 25 foot timed walk;
9HPT: nine hole peg test; DVR: distribution volume ratio;
NAWM: normal-appearing white matter.

linear regression of clinical scores (EDSS or MSFC
and its components, 25 foot timed walk, nine hole
peg test (9HPT) and three second paced auditory
serial addition test (PASAT-3)) was performed using
a general linear model with normalised whole brain
grey matter volume, TSPO DVR, myo-inositol and
NAA as predictor variables.
Results
A total of 24 people with clinically definite MS underwent [11C]PBR28 PET, single voxel MRS and structural MRI scanning (Table 1, Figure 1). One patient
was excluded from the final analysis because noise
artefacts precluded reliable estimates of metabolite
concentrations. Of the 23 remaining patients (nine
men, median age 48 years, range 22-66 years)
included in the final analysis, 7 had a diagnosis of secondary progressive disease and 16 had relapsingremitting disease. The median EDSS was 5.0 (range,
1.0-7.0). WMLs were found within the spectroscopy
voxel for all patients. None of these lesions was gadolinium enhancing.

Differences in [11C]PBR28 uptake are not
correlated with brain [myo-inositol]
The concentration of myo-inositol in the spectroscopy voxel (expressed as either an absolute concentration or as a ratio to total tissue creatine) was not
significantly correlated to the TSPO binding
journals.sagepub.com/home/msj


https://journals.sagepub.com/home/msj

Table of Contents for the Digital Edition of Multiple Sclerosis Journal - October 2017

Contents
Multiple Sclerosis Journal - October 2017 - Cover1
Multiple Sclerosis Journal - October 2017 - Cover2
Multiple Sclerosis Journal - October 2017 - Contents
Multiple Sclerosis Journal - October 2017 - ii
Multiple Sclerosis Journal - October 2017 - iii
Multiple Sclerosis Journal - October 2017 - 1436
Multiple Sclerosis Journal - October 2017 - 1437
Multiple Sclerosis Journal - October 2017 - 1438
Multiple Sclerosis Journal - October 2017 - 1439
Multiple Sclerosis Journal - October 2017 - 1440
Multiple Sclerosis Journal - October 2017 - 1441
Multiple Sclerosis Journal - October 2017 - 1442
Multiple Sclerosis Journal - October 2017 - 1443
Multiple Sclerosis Journal - October 2017 - 1444
Multiple Sclerosis Journal - October 2017 - 1445
Multiple Sclerosis Journal - October 2017 - 1446
Multiple Sclerosis Journal - October 2017 - 1447
Multiple Sclerosis Journal - October 2017 - 1448
Multiple Sclerosis Journal - October 2017 - 1449
Multiple Sclerosis Journal - October 2017 - 1450
Multiple Sclerosis Journal - October 2017 - 1451
Multiple Sclerosis Journal - October 2017 - 1452
Multiple Sclerosis Journal - October 2017 - 1453
Multiple Sclerosis Journal - October 2017 - 1454
Multiple Sclerosis Journal - October 2017 - 1455
Multiple Sclerosis Journal - October 2017 - 1456
Multiple Sclerosis Journal - October 2017 - 1457
Multiple Sclerosis Journal - October 2017 - 1458
Multiple Sclerosis Journal - October 2017 - 1459
Multiple Sclerosis Journal - October 2017 - 1460
Multiple Sclerosis Journal - October 2017 - 1461
Multiple Sclerosis Journal - October 2017 - 1462
Multiple Sclerosis Journal - October 2017 - 1463
Multiple Sclerosis Journal - October 2017 - 1464
Multiple Sclerosis Journal - October 2017 - 1465
Multiple Sclerosis Journal - October 2017 - 1466
Multiple Sclerosis Journal - October 2017 - 1467
Multiple Sclerosis Journal - October 2017 - 1468
Multiple Sclerosis Journal - October 2017 - 1469
Multiple Sclerosis Journal - October 2017 - 1470
Multiple Sclerosis Journal - October 2017 - 1471
Multiple Sclerosis Journal - October 2017 - 1472
Multiple Sclerosis Journal - October 2017 - 1473
Multiple Sclerosis Journal - October 2017 - 1474
Multiple Sclerosis Journal - October 2017 - 1475
Multiple Sclerosis Journal - October 2017 - 1476
Multiple Sclerosis Journal - October 2017 - 1477
Multiple Sclerosis Journal - October 2017 - 1478
Multiple Sclerosis Journal - October 2017 - 1479
Multiple Sclerosis Journal - October 2017 - 1480
Multiple Sclerosis Journal - October 2017 - 1481
Multiple Sclerosis Journal - October 2017 - 1482
Multiple Sclerosis Journal - October 2017 - 1483
Multiple Sclerosis Journal - October 2017 - 1484
Multiple Sclerosis Journal - October 2017 - 1485
Multiple Sclerosis Journal - October 2017 - 1486
Multiple Sclerosis Journal - October 2017 - 1487
Multiple Sclerosis Journal - October 2017 - 1488
Multiple Sclerosis Journal - October 2017 - 1489
Multiple Sclerosis Journal - October 2017 - 1490
Multiple Sclerosis Journal - October 2017 - 1491
Multiple Sclerosis Journal - October 2017 - 1492
Multiple Sclerosis Journal - October 2017 - 1493
Multiple Sclerosis Journal - October 2017 - 1494
Multiple Sclerosis Journal - October 2017 - 1495
Multiple Sclerosis Journal - October 2017 - 1496
Multiple Sclerosis Journal - October 2017 - 1497
Multiple Sclerosis Journal - October 2017 - 1498
Multiple Sclerosis Journal - October 2017 - 1499
Multiple Sclerosis Journal - October 2017 - 1500
Multiple Sclerosis Journal - October 2017 - 1501
Multiple Sclerosis Journal - October 2017 - 1502
Multiple Sclerosis Journal - October 2017 - 1503
Multiple Sclerosis Journal - October 2017 - 1504
Multiple Sclerosis Journal - October 2017 - 1505
Multiple Sclerosis Journal - October 2017 - 1506
Multiple Sclerosis Journal - October 2017 - 1507
Multiple Sclerosis Journal - October 2017 - 1508
Multiple Sclerosis Journal - October 2017 - 1509
Multiple Sclerosis Journal - October 2017 - 1510
Multiple Sclerosis Journal - October 2017 - 1511
Multiple Sclerosis Journal - October 2017 - 1512
Multiple Sclerosis Journal - October 2017 - 1513
Multiple Sclerosis Journal - October 2017 - 1514
Multiple Sclerosis Journal - October 2017 - 1515
Multiple Sclerosis Journal - October 2017 - 1516
Multiple Sclerosis Journal - October 2017 - 1517
Multiple Sclerosis Journal - October 2017 - 1518
Multiple Sclerosis Journal - October 2017 - 1519
Multiple Sclerosis Journal - October 2017 - 1520
Multiple Sclerosis Journal - October 2017 - 1521
Multiple Sclerosis Journal - October 2017 - 1522
Multiple Sclerosis Journal - October 2017 - 1523
Multiple Sclerosis Journal - October 2017 - 1524
Multiple Sclerosis Journal - October 2017 - 1525
Multiple Sclerosis Journal - October 2017 - 1526
Multiple Sclerosis Journal - October 2017 - 1527
Multiple Sclerosis Journal - October 2017 - 1528
Multiple Sclerosis Journal - October 2017 - 1529
Multiple Sclerosis Journal - October 2017 - 1530
Multiple Sclerosis Journal - October 2017 - 1531
Multiple Sclerosis Journal - October 2017 - 1532
Multiple Sclerosis Journal - October 2017 - 1533
Multiple Sclerosis Journal - October 2017 - 1534
Multiple Sclerosis Journal - October 2017 - 1535
Multiple Sclerosis Journal - October 2017 - 1536
Multiple Sclerosis Journal - October 2017 - 1537
Multiple Sclerosis Journal - October 2017 - 1538
Multiple Sclerosis Journal - October 2017 - 1539
Multiple Sclerosis Journal - October 2017 - 1540
Multiple Sclerosis Journal - October 2017 - 1541
Multiple Sclerosis Journal - October 2017 - 1542
Multiple Sclerosis Journal - October 2017 - 1543
Multiple Sclerosis Journal - October 2017 - 1544
Multiple Sclerosis Journal - October 2017 - 1545
Multiple Sclerosis Journal - October 2017 - 1546
Multiple Sclerosis Journal - October 2017 - 1547
Multiple Sclerosis Journal - October 2017 - 1548
Multiple Sclerosis Journal - October 2017 - 1549
Multiple Sclerosis Journal - October 2017 - 1550
Multiple Sclerosis Journal - October 2017 - 1551
Multiple Sclerosis Journal - October 2017 - 1552
Multiple Sclerosis Journal - October 2017 - 1553
Multiple Sclerosis Journal - October 2017 - 1554
Multiple Sclerosis Journal - October 2017 - 1555
Multiple Sclerosis Journal - October 2017 - 1556
Multiple Sclerosis Journal - October 2017 - 1557
Multiple Sclerosis Journal - October 2017 - 1558
Multiple Sclerosis Journal - October 2017 - 1559
Multiple Sclerosis Journal - October 2017 - 1560
Multiple Sclerosis Journal - October 2017 - 1561
Multiple Sclerosis Journal - October 2017 - 1562
Multiple Sclerosis Journal - October 2017 - 1563
Multiple Sclerosis Journal - October 2017 - 1564
Multiple Sclerosis Journal - October 2017 - 1565
Multiple Sclerosis Journal - October 2017 - 1566
Multiple Sclerosis Journal - October 2017 - Cover3
Multiple Sclerosis Journal - October 2017 - Cover4
https://www.nxtbookmedia.com